Once more unto the breach, dear friends, once more, Or close the wall up with our English dead! In peace there's nothing so becomes a man As modest stillness and humility, But when the blast of war blows in our ears, Then imitate the action of the tiger: Stiffen the sinews, summon up the blood.
-William Shakespeare (King Henry, Henry V) Donald Metcalf-Professor Metcalf to those younger colleagues who were meeting him for the first time and Don to everyone else-was one of the fathers of modern hematology, shaping the field for the 60 years of his working life In an age when scientific superstars run mega-labs and often move from institution to institution chasing ever more lucrative packages, the opposite was true of Don. Throughout his entire career, he was supported by the same fellowship and worked at the same institution. Despite his burgeoning reputation, he never left the laboratory bench and conducted experiments himself with the support of one or two research assistants and an occasional graduate student. Having studied thymus development and lymphomagenesis for a decade, Don's epiphany came in 1965, when with Ray Bradley at The University of Melbourne, he used semi-solid culture medium containing a crude source of growth factor to grow colonies of granulocytes and macrophages from their precursors in the bone marrow. Don realized immediately that this technique would not only permit him to map the hierarchical relationship between multipotential stem cells, committed progenitors, and their differentiating progeny, but would also allow him to define the hormones that regulated the process. Don worked on nothing else for the next 50 years and, in doing so, made the blood cell system the poster child for understanding tissue renewal.
Don named the hormones that stimulated the growth of blood cells colonystimulating factors, or CSFs. Unlike classic hormones, which are produced by a single tissue or cell type and act widely, Don found CSFs to be produced by almost every tissue he examined, but in vanishingly small amounts, and to act on a limited set of target cells. This resulted in a huge degree of skepticism in the scientific community; many thought that CSFs were in vitro artifacts that were of little importance to the regulation of blood cell production in vivo. Skepticism was the spur that Don relished. Recruiting a series of protein chemists and molecular biologists to the collaborative cause, including Richard Stanley, Tony Burgess, Nicos Nicola, Ashley Dunn, and Nick Gough, Don orchestrated a 30-year collaboration that saw the purification to homogeneity of four colony-stimulating factors: granulocyte CSF (G-CSF), macrophage CSF (M-CSF), granulocytemacrophage CSF (GM-CSF), and multi-CSF, which is now better known as interleukin-3.
The purification of the CSFs led to the cloning of their genes-GM-CSF by Don's team in Melbourne and G-CSF, M-CSF, and IL-3 by others-and ultimately led to the mass production of CSFs, allowing Don to do the experiment about which he had dreamed for 30 years: injecting pure recombinant CSFs into animals and seeing whether blood cell production becomes elevated. The answer was an emphatic yes, and these in vivo experiments paved the way for the successful use of G-CSF and GM-CSF in elevating the level of white cells in patients undergoing chemotherapy for cancer to reduce the likelihood of infection due to leukopenia. It was during these clinical trials that Don and a postdoctoral fellow, Uli Dü hrsen, discovered that, upon injection of patients with G-CSF, stem cells migrated from the bone marrow into the peripheral blood. This observation rapidly led to the use of G-CSF as an agent to mobilize stem cells, meaning that they could be obtained by simple blood collection rather than the more complicated and painful bone marrow harvest. This revolutionized bone marrow transplantation, making it safer, more effective, and more broadly applicable. It is estimated that more than 20 million people have benefitted from Don's discoveries, including the Spanish tenor José Carreras, who was an early recipient of the therapy.
Don's profound discoveries led to countless distinguished lectureships, awards, and prizes, including Don detested spin-he wanted his data to speak for itself and was scathing of researchers he termed ''prancers'' or ''strutters,'' who were more showmen than scientists. At conferences and in seminars, he would ask the incisive question or, if required, deliver the acerbic assessment-the more famous the researcher, the more pointed and colorful the criticism if the talk was not up to par. He was happy to send his papers to specialty hematology journals, and unless badgered by ambitious junior colleagues, Don eschewed what he called ''fancy'' journals, which he thought required sensationalization of the story.
Don was comfortable working in Melbourne, which for those in Boston, San Francisco, London, or Paris seemed like the end of the Earth. This tyranny of distance was actually a great source of comfort to Don, who could follow his own scientific compass without being blown off course by trends or fads. Don was deeply suspicious of researchers who, on achieving a level of success, retreated out of the laboratory into the safety of their office. He was a man who led from the experimental front for his whole life, which is why he so liked the ''Once more unto the breach'' speech of Henry V and titled his autobiography Summon Up The Blood. He worked five and a half days a week for most of the last 50 years, with his only concession to age being an occasional Saturday off and leaving work a little early to avoid the traffic in the evening.
Other than a bad back, which was no doubt exacerbated by endless hours working at the microscope, Don remained in remarkable health until the middle of last year. Feeling ''off color,'' Don and his beloved wife of 60 years, Josephine, took a vacation, which he hoped would reinvigorate him for another decade of discovery. Returning in August feeling worse, Don suspected the worst and was quickly diagnosed with metastatic pancreatic cancer. Knowing the chance of cure was slim, Don had two concerns: to finish off the experiments awaiting his return from vacation and to spend as much time as possible with his family. But how to do both? The answer was to have his microscope moved from his laboratory to his dining room table at home and to do experiments when his chemotherapy schedule allowed. Don carried out his last experiment in November, when his health began to decline precipitously. He died on December 15, 2014, surrounded by his wife Jo and their four daughters and their families. Don was an experimentalist and a family man to the end. He would have wanted it no other way.
